Cardinal spins off medical technology business
Cardinal Health will spin off its medical technology businesses as a separate public company, leaving Cardinal with its pharmaceutical and medical product distribution business. Cardinal CEO Kerry Clark will retire from the company after completion of the spinoff, to be succeeded by current health care supply chain services CEO George Barrett. David Schlotterbeck, CEO of clinical and medical products, will head the new company, to be headquartered in San Diego. The proposed tax-free spinoff will be done through a pro rata distribution to Cardinal shareholders and is expected to be completed in mid-2009. Cardinal discussed the potential benefits of a spinoff during its most recent quarterly earnings call (1"The Pink Sheet," Aug. 11, 2008, p. 22)
You may also be interested in...
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.